Organovo Holdings (ONVO) Receiving Somewhat Favorable Press Coverage, Report Finds
News articles about Organovo Holdings (NASDAQ:ONVO) have been trending somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Organovo Holdings earned a coverage optimism score of 0.04 on Accern’s scale. Accern also assigned media headlines about the company an impact score of 46.3625327938246 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.
Here are some of the news stories that may have impacted Accern Sentiment’s rankings:
- Organovo Holdings, Inc. (ONVO) Given Average Recommendation of “Hold” by Analysts (americanbankingnews.com)
- Trading summary on Organovo Holdings, Inc. (ONVO) – Wall Street Morning (wallstreetmorning.com)
- Organovo Holdings, Inc. (NASDAQ:ONVO) soon to be worth around $4.67, financial analysts predict – AllStockNews (allstocknews.com)
- Global 3D printing for medical sector market was valued at US$ 412.2 million in 2015 (reports.pr-inside.com)
Shares of Organovo Holdings (NASDAQ:ONVO) opened at 2.34 on Thursday. The stock’s 50 day moving average price is $2.11 and its 200-day moving average price is $2.64. The firm’s market cap is $248.33 million. Organovo Holdings has a 12-month low of $1.75 and a 12-month high of $4.21.
Organovo Holdings (NASDAQ:ONVO) last announced its quarterly earnings data on Wednesday, August 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.10). The firm had revenue of $0.99 million during the quarter, compared to the consensus estimate of $0.92 million. Organovo Holdings had a negative return on equity of 65.49% and a negative net margin of 918.97%. The company’s revenue for the quarter was up 11.1% compared to the same quarter last year. On average, analysts predict that Organovo Holdings will post ($0.39) earnings per share for the current fiscal year.
Several equities research analysts have issued reports on ONVO shares. Jefferies Group LLC reaffirmed a “buy” rating and set a $4.00 price target on shares of Organovo Holdings in a report on Thursday, July 27th. Evercore ISI reaffirmed an “outperform” rating and set a $3.75 price target (down previously from $4.00) on shares of Organovo Holdings in a report on Friday, June 9th. ValuEngine downgraded Organovo Holdings from a “sell” rating to a “strong sell” rating in a report on Friday, September 1st. Finally, BidaskClub downgraded Organovo Holdings from a “sell” rating to a “strong sell” rating in a report on Tuesday, July 25th. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the stock. Organovo Holdings has a consensus rating of “Hold” and an average price target of $6.20.
COPYRIGHT VIOLATION WARNING: This piece was reported by Daily Political and is the property of of Daily Political. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2017/09/14/organovo-holdings-onvo-receiving-somewhat-favorable-press-coverage-report-finds.html.
Organovo Holdings Company Profile
Receive News & Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.